Lonafarnib-A new member of the Delta Force?

Christopher A Dietz¹, Markus Cornberg^{1

2

3}

Affiliations

¹ Department of Gastroenterology, Hepatology and EndocrinologyHannover Medical SchoolHannoverGermany.
² Center for Individualized Infection Medicine, a joint venture between the Helmholtz Center for Infection Research and Hannover Medical SchoolHannoverGermany.
³ German Center for Infection Researchpartner site Hannover-BraunschweigGermany.

Editorial

Christopher A Dietz et al. Hepatology. 2022 Jun.

. 2022 Jun;75(6):1370-1372.

doi: 10.1002/hep.32435. Epub 2022 Mar 13.

Christopher A Dietz¹, Markus Cornberg^{1

2

3}

¹ Department of Gastroenterology, Hepatology and EndocrinologyHannover Medical SchoolHannoverGermany.
² Center for Individualized Infection Medicine, a joint venture between the Helmholtz Center for Infection Research and Hannover Medical SchoolHannoverGermany.
³ German Center for Infection Researchpartner site Hannover-BraunschweigGermany.

No abstract available

Comment on

A phase 2 dose-finding study of lonafarnib and ritonavir with or without interferon alpha for chronic delta hepatitis.
Yurdaydin C, Keskin O, Yurdcu E, Çalişkan A, Önem S, Karakaya F, Kalkan Ç, Karatayli E, Karatayli S, Choong I, Apelian D, Koh C, Heller T, Idilman R, Bozdayi AM, Glenn JS. Yurdaydin C, et al. Hepatology. 2022 Jun;75(6):1551-1565. doi: 10.1002/hep.32259. Epub 2021 Dec 23. Hepatology. 2022. PMID: 34860418 Clinical Trial.

1. Rizzetto M, Hamid S, Negro F. The changing context of hepatitis D. J Hepatol. 2021;74:1200–11.
1. Lau DT, Doo E, Park Y, Kleiner DE, Schmid P, Kuhns MC, et al. Lamivudine for chronic delta hepatitis. Hepatology. 1999;30:546–9.
1. Wedemeyer H, Yurdaydìn C, Dalekos GN, Erhardt A, Çakaloğlu Y, Değertekin H, et al. Peginterferon plus adefovir versus either drug alone for hepatitis delta. N Engl J Med. 2011;364:322–31.
1. Sandmann L, Cornberg M. Experimental drugs for the treatment of hepatitis D. J Exp Pharmacol. 2021;13:461–8.
1. Wranke A, Serrano BC, Heidrich B, Kirschner J, Bremer B, Lehmann P, et al. Antiviral treatment and liver‐related complications in hepatitis delta. Hepatology. 2017;65:414–25.